Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,841 | 7,024 | 22,936 | -4,805 | -7,650 |
| Depreciation Amortization | 2,262 | 1,081 | 4,817 | 3,597 | 2,332 |
| Income taxes - deferred | -637 | 498 | 5,589 | 9,418 | 9,297 |
| Accounts receivable | -3,634 | -2,701 | 24,514 | 1,318 | 23,934 |
| Accounts payable and accrued liabilities | 1,993 | -1,757 | -12 | 1,521 | -1,613 |
| Other Working Capital | -11,956 | -13,871 | 25,543 | -27,092 | -12,018 |
| Other Operating Activity | 2,444 | 4,698 | -27,940 | -7,652 | -27,869 |
| Operating Cash Flow | $-687 | $-5,028 | $55,447 | $-23,695 | $-13,587 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,543 | -6,931 | -43,969 | -36,197 | -27,343 |
| Other Investing Activity | -10,000 | -3,500 | 0 | 0 | 0 |
| Investing Cash Flow | $-22,543 | $-10,431 | $-43,969 | $-36,197 | $-27,343 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 30,000 | 15,000 | 33,195 | 15,333 | N/A |
| Debt Repayment | -28,622 | -12,708 | -18,015 | -11,131 | -10,154 |
| Common Stock Issued | 214 | N/A | 2,471 | 2,474 | 2,419 |
| Other Financing Activity | 0 | 0 | 840 | 1,708 | 6,708 |
| Financing Cash Flow | $1,592 | $2,292 | $18,491 | $8,384 | $-1,027 |
| Exchange Rate Effect | -85 | 184 | -657 | -644 | -481 |
| Beginning Cash Position | 105,730 | 105,730 | 76,418 | 76,418 | 76,418 |
| End Cash Position | 84,007 | 92,747 | 105,730 | 24,266 | 33,980 |
| Net Cash Flow | $-21,723 | $-12,983 | $29,312 | $-52,152 | $-42,438 |
| Free Cash Flow | |||||
| Operating Cash Flow | -687 | -5,028 | 55,447 | -23,695 | -13,587 |
| Capital Expenditure | -12,543 | -6,931 | -43,969 | -36,197 | -27,343 |
| Free Cash Flow | -13,230 | -11,959 | 11,478 | -59,892 | -40,930 |